| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant Use of Taxanes for Patients with Breast Cancer: We See the Tip of the Iceberg
|
Hudis, Clifford
|
|
2002
|
3 |
5 |
p. 326-332
7 p.
|
article
|
| 2 |
2002 Highlights from: 27th European Society of Medical Oncology Congress, Nice, France, October 18–22
|
DeGrendele, Heather
|
|
2002
|
3 |
5 |
p. 302-306
5 p.
|
article
|
| 3 |
Local Control of Breast Cancer: Issues and Answers
|
George Jr., George W.
|
|
2002
|
3 |
5 |
p. 301-
1 p.
|
article
|
| 4 |
Microtubule-Associated Parameters as Predictive Markers of Docetaxel Activity in Advanced Breast Cancer Patients: Results of a Pilot Study
|
Bernard-Marty, Chantal
|
|
2002
|
3 |
5 |
p. 341-345
5 p.
|
article
|
| 5 |
Optimizing the Efficacy of Trastuzumab: An Update of Research Efforts
|
Lee, David
|
|
2002
|
3 |
5 |
p. 312-314
3 p.
|
article
|
| 6 |
Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58
|
Smith, Roy E.
|
|
2002
|
3 |
5 |
p. 333-340
8 p.
|
article
|
| 7 |
Recent Studies with Anastrozole Versus Tamoxifen in the Management of Breast Cancer
|
Gibson, Angelia D.
|
|
2002
|
3 |
5 |
p. 309-311
3 p.
|
article
|
| 8 |
To Dissect or Not To Dissect?—That Is the Question
|
Reintgen, Douglas
|
|
2002
|
3 |
5 |
p. 323-325
3 p.
|
article
|
| 9 |
Toward Re-expressing Tumor Suppressor Gene Maspin in Breast Cancer
|
Zhang, Ming
|
|
2002
|
3 |
5 |
p. 353-354
2 p.
|
article
|
| 10 |
Weekly Docetaxel/Paclitaxel in Pretreated Metastatic Breast Cancer
|
Gennari, Alessandra
|
|
2002
|
3 |
5 |
p. 346-352
7 p.
|
article
|
| 11 |
Will We Need Lymph Node Dissection at All in the Future?
|
Bourez, Robert L.J.H.
|
|
2002
|
3 |
5 |
p. 315-322
8 p.
|
article
|
Journal description